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ABSTRACT 
 
Role of Vaccination in the Control of Turkey Coccidiosis: Vaccine Associated Oocyst 
Shedding, Lesions, and Mucosal Gene Expression. (May 2011) 
Michelle A. Behl, B.S., University of Wisconsin-Madison 
Chair of Advisory Committee: Dr. Morgan Farnell 
  
Coccidiosis vaccine associated side effects, oocyst shedding patterns, intestinal 
lesions, and mucosal gene expression in the turkey were studied.  The first study 
examined vaccine associated side effects and oocyst shedding patterns under 
experimental conditions.  Peak oocyst shedding occurred on days 5-6, 13-17, and 19-20 
days post vaccination.  Throughout the course of the study, several poults exhibited 
clinical coccidiosis.  Based on body weights, growth was correlated with vaccine 
cycling.  
The second study examined coccidiosis vaccine induced lesions and changes in 
mucosal gene expression on day 5, 10, 13, 17, and 20 days post vaccination.  Poults were 
gavaged the equivalent of 0x, 1/2x, 1x, and 2x the available vaccine dose.  Intestinal 
sections adjacent to the Meckel‟s diverticulum, ileocecal junction, and middle of the 
ceca were collected for histological analysis and gene expression.  Measurements from 
the tip of the villus to the base of the lamina propria, villus width, and the muscularis 
mucosae thickness were acquired from the histological sections.  Interleukin-10, IL-1β, 
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and GAPDH gene expression were measured by extracting mRNA in the tissues and 
quantified using real-time RT-qPCR.   
Starting on day five post vaccination, the control group weighed significantly 
more than the group that received the 2x dose.  Body weight and oocyst dose were 
inversely related through day 17.  Intestinal measurements did not necessarily correlate 
with the vaccine dose, although there appears to be some correlation on day five.  There 
were no significant changes in the mucosal gene expression of IL-10 and IL-1β in the 
intestinal tissue adjacent to the Meckel‟s diverticulum throughout the course of the 
study.  On day five post vaccination, IL-10 and IL-1β were significantly upregulted in 
the ileocecal junction.  Interleukin-10 was significantly upregulated on day 17 and IL-1β 
was significanlty down regulated on day 20 in the ileocecal junction.  Both IL-10 and 
IL-1β were significanlty upregulated in the ceca days 5, 10, and 13 post vaccination.  
Interleukin-10 was significnalty upregulated in the ceca on day 17 and significantly 
down regulated on day 20.  Individual variation among poults in the same group merits 
further attention. 
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NOMENCLATURE 
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GAPDH Glyceraldehyde 3-Phosphate Dehydrogenase 
ICJ Ileocecal Junction 
IEC Intraepithelial Cell 
IL Interleukin  
ISCOM Immune Stimulating Complexes 
MD Meckel‟s Diverticulum 
mRNA Messenger RNA 
OPG Oocyst per Gram 
qRT-PCR Quantitative Real Time Polymerase Chain Reaction 
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CHAPTER I 
INTRODUCTION 
  
Avian coccidiosis is caused by infections with the intestinal protozoa of the 
phylum Apicomplexa and genus Eimeria.  The disease most notably characterized by 
diarrhea and enteritis, is a universal problem in the poultry industry.  When considering 
treatment costs and lost performance, the disease costs the industry an estimated $3 
billion dollars each year worldwide, making it the most expensive disease affecting the 
poultry industry today (Dalloul and Lillehoj, 2006).  Traditionally, the poultry industry 
has relied heavily on the use of anticoccidial medications to prevent or treat the disease 
(Williams, 2002).  Unfortunately, Eimeria easily develop resistance to chemicals and 
antibiotics making them less effective for long-term treatment (Li et al., 2004).  A recent 
field study conducted by Chapman and Rathinam (2007) revealed the majority of turkey 
strains of Eimeria are either partially or fully resistant to the commonly used ionophore, 
monensin.  The growing demand for naturally raised poultry products and increasing 
chemical resistance has fueled the need to find alternative methods to prophylactic 
treatments for the control of coccidiosis.  Consequently, intensive rearing systems favor 
the Eimeria life cycle (Long, 1984) therefore the threat of coccidiosis is unlikely to 
disappear.  When compared to chemical coccidiostats, coccidial vaccines are relatively 
new for turkeys.  The first chemical treatment appeared approximately 70 years ago  
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while the first coccidial turkey vaccine, Coccivac-T®, appeared only 21 years ago.  
Comparatively, the first chicken vaccine was formulated nearly 60 years ago (Williams, 
2002).  Although vaccines appear to be a viable alternative to prophylactic treatment, 
side effects such as post-vaccinal setbacks in weight gain have limited their acceptance 
(Danforth, 1998).   
 
Rationale and Significance  
Due to limited peer reviewed data concerning turkey coccidiosis vaccination, 
Willmar Poultry Farms (WPF) (Willmar, MN) conducted a series of trials to determine 
the efficacy of Coccivac-T® in their commercial system.  For a three month period, 
Coccivac-T® vaccination replaced the traditionally used ionophore, monensin on all 
poult placements in the WPF commercial system.  The vaccine was administered at the 
hatchery using a Spraycox
®
 II cabinet (Intervet/Schering-Plough Animal Health) or a 
proprietary experimental gel drip bar with supplemental lighting (Danisco®, Madison, 
WI).  Vaccine uptake was measured by assessing residual vaccine dye on the inside of 
the beak 15 minutes post vaccination.  Although the gel drip bar averaged 85% uptake 
versus the spray at 75%, both application methods resulted in highly variable vaccine 
uptake (unpublished).  Factors such as hatch timing, hydration of the poult, and inherent 
pecking order probably played a role in vaccine uptake.  Later hatching or extremely 
hydrated poults consumed less than the earlier hatching, less hydrated poults.  
Inconsistent consumption also occurred with poults that were comparable in hatch 
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timing and hydration level (unpublished).  Naturally, aggressive poults consumed more 
droplets than docile ones.    
In the field, clinical coccidiosis was diagnosed to some extent in most flocks 
vaccinated with Coccivac-T®.  Poults developed enteritis at approximately 10 days of 
age and exhibited ruffled feathers, general morbidity, and a decrease in flock uniformity.  
Examination of the intestinal scrapings from the mortalities and fecal droppings in the 
barn revealed excessive amounts of oocysts.  Oocyst levels in scrapings that were too 
numerous to count could be seen as early as day seven.  In an attempt to control the 
clinical coccidiosis, flocks were treated with amprollium during brooding to reduce 
oocyst levels (unpublished data).    
Coccidiosis and coccidiosis vaccination have been studied in the chicken but to a 
lesser extent in the turkey.  The nature of the disease is somewhat different between the 
two hosts (Saif, 2003); therefore, information collected in the chicken may not be fully 
applicable to the turkey.  Clinical signs are not easily detected in the turkey because 
lesions heal quickly, making coccidiosis difficult to diagnose (Saif, 2003).  A better 
understanding of the disease in the turkey may provide an insight to control it.   
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CHAPTER II 
LITERATURE REVIEW 
 
Coccidia 
Coccidia are single-cell, obligate intracellular parasites, of the genus Eimeria, 
which invade the epithelial lining of the gastrointestinal tract.  Multiplication of the 
parasite in the epithelium results in tissue damage, nutrient malabsorption, blood loss, 
and infections with opportunistic pathogens such as Clostridium perfringens (Collier et 
al, 2008).  Species of Eimeria are host specific, unique to the area of the gastrointestinal 
tract that it invades, and lesions it produces.  Cross immunity between species of 
Eimeria does not exist (Saif, 2003; Charlton, 2006).    
The life cycle of coccidia is very complex and consists of both asexual and 
sexual reproductive stages.  The life cycle also includes a sporogony phase in which a 
thick wall protects the parasite making it very resistant to drying and many chemical 
substances, enabling it to survive for extended periods in the environment (Saif, 2003).  
Coccidiosis is initiated upon the ingestion of a sporulated oocyst.  Once in the 
gastrointestinal tract, enzymatic secretions coupled with the mechanical action of the 
ventriculus cause the oocyst to rupture and release eight sporozoites from four 
sporocytes enclosed in the oocyst (Conway et al. 1991).  The sporozoites invade the 
epithelial cells of the villi and migrate to the epithelium in the crypt for asexual 
proliferation (Yun et al., 2000).  Upon invasion, the sporozoite transforms into the 
feeding stage of its life and becomes a trophozite.  The trophozite feeds upon the 
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epithelial cells and continues to grow larger until it is large enough to undergo division 
by asexual reproduction and develop into a schizont.  When the schizont ruptures, it 
releases thousands of merozoites that invade other cells.  This cycle repeats several 
times, depending on the species of Eimeria involved, before male and female gametes 
known as microgametes and macrogametes form.  Once the microgamete fertilizes the 
macrogamete, a thick wall develops around the zygote and gives rise to an immature 
oocyst.  When the enterocyte cell wall ruptures, the immature oocyst is passed in the 
feces.  Ingestion of a single oocyst can result in the shedding of up to one million 
oocysts and result in extensive tissue damage (Conway et al., 1991).  The oocyst must 
mature in the environment in order to become infectious.  Oxygen, heat, and moisture 
are required for sporulation.  Up to 20% of ingested unsporulated vaccine oocysts can 
pass through the gastrointestinal tract undamaged and later sporulate and become 
infectious (Williams, 1998). 
Seven species of Eimeria are known to infect the turkey.  Only four of them are 
considered pathogenic: Eimeria meleagrimitis, Eimeria dispersa, Eimeria gallapovonis, 
and Eimeria adenoeides.  Eimeria meleagrimitis tends to parasitize the middle one-third 
of the small intestine.  Eimeria dispersa is found across the small intestine and ileocecal 
junction.  Eimeria gallapovonis affect the lower portion of the ileum, ileocecal junction, 
and large intestine.  Eimeria adenoeides may cause occasional lesions across the lower 
one-third of the intestine but primarily affects the ceca.  Non-pathogenic species of 
Eimeria may be found in the gastrointestinal tract.  Therefore, diagnosis of coccidiosis 
needs to be based on clinical signs and pathological lesions rather than solely on the 
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presence of coccidia in the gut alone (Saif, 2003; Charlton, 2006).  Coccidiasis is 
described as a subclinical coccidial infection.  Coccidiosis is a symptomatic infection, 
which results in clinical signs (Charlton, 2006).  
 
Avian Immune Response 
The avian immune system differs to some extent from the mammalian immune 
system in structure and functionality (Bar Shira et al., 2003).  Chickens appear to lack 
some of the TH2 components of the immune response found in mammals such as the 
immunoglobulin (Ig) E that helps combat the extracellular stages of Eimeria.  In 
addition, chickens have fewer mast cells that are notably involved with IgE pathogen 
defenses against protozoan parasites in mammals (Kaiser et al., 2004).  Understanding 
the protective immunological response of the avian intestine may help to discover new 
ways to controlling infections with Eimeria (Lillehoj 1998; Hilton et al., 2002).  The 
intestine is the largest immunological organ in the bird and its response to challenges 
with Eimeria is multifaceted (Lillehoj 1998).  The immune mechanisms involved are 
dependent upon the area of the gastrointestinal tract being parasitized, the Eimeria 
species involved, and the developmental stage of the coccidial parasite (Lillehoj, 1998; 
Talabia and Mulcahy, 2005).  The early asexual stages of the Eimeria life cycle are more 
immunogenic than the later sexual stages (Yun et al., 2000).  The propagation of the 
pathogen and the immune response is not always predictable.  Gross lesion scores do not 
necessarily increase linearly with the number of oocysts ingested (Conway et al., 1999).  
The immune response to Eimeria may not always be beneficial to the host either.  The 
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host‟s inflammatory defense response to coccidia increases mucogenesis in the 
gastrointestinal tract.  Clostridium perfringens is able to utilize mucus as a substrate in 
the gut therefore making the gastrointestinal tract a more favorable environment for the 
growth of Clostridium perfringens.  The increase in Clostridia colonies in the gut 
contributes to the onset of necrotic enteritis in chickens (Collier et al., 2008).   
 
Immune Response to Eimeria 
When Eimeria invades the gastrointestinal tract, intraepithelial cells (IEC‟s), 
primary immune effector cells, located throughout the gastrointestinal tract, are 
responsible for eliciting a protective immunity to coccidiosis (Kim et al., 2008).  
Intraepithelial leukocytes are comprised of several cell types that regulate the mucosal 
immune response through the secretion of cytokines (Yun et al., 2000).  Numerous 
cytokines are immediately produced locally to provide the early signs of invasion and 
enhance the immune response (Dalloul and Lillehoj, 2005).  These cytokines activate 
lymphocytes and stimulate the secretion of IgA that is the gastrointestinal tract‟s first 
line of defense (Lowenthal et al., 2000).  Secretory IgA can attach to the coccidial 
surface and prevent the binding of the pathogen to the epithelial surface by directly 
blocking attachment, through steric hindrance, or by decreasing the motility of the 
sporozoites.  Cytokines promote antigen processing of immune cells such as the B and T 
cells.  A complex interaction occurs between the regulation of cytokines and host‟s 
immune response to Eimeria.  Intracellular stages of the Eimeria life cycle activate cell-
mediated immunity while the extracellular stages activate humoral responses (Yun et al., 
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2000).  Cell-mediated immunity appears to play a much larger role than the humoral 
antibody response when considering Eimeria resistance (Lillehoj, 1998; Talabia and 
Mulcahy, 2005).  The Natural killer cells play an important role in the early local 
defense while T cells play a much larger role in the development of natural resistance to 
Eimeria (Vermeulen, 1998).  Cytokines, interleukin (IL)-1β (Kaiser et al., 2004), IL-2, 
IL-5, IL- 10, (Yun et al., 2000), and IFN-γ (Lillehoj, 1998) are significantly up regulated 
in regions across the gastrointestinal tract following challenges with Eimeria.  A cDNA 
microarray of over four-hundred genes in the intestinal intraepithelial lymphocytes 
during primary and secondary Eimeria maxima infections in leghorn chickens revealed 
significant changes in IL-1β, IL-2, IL-6, IL-8, IL-15, and IL-18 (Kim et al., 2008).  
 
Interleukin-10 
Interleukin-10, secreted by activated macrophages and T-regulatory cells, is one 
of the most important immunoregulatory cytokines.  It helps to maintain balance of the 
innate and cell medicated immune responses by inhibiting activated macrophages 
(Abbass et. al, 2007) and inflammation (Kaiser et al., 2004).  During peak parasitic 
infections in chickens, IL-10 expression is elevated.  The increase in IL-10 may be an 
attempt of the parasite to evade macrophage-mediated destruction by suppressing the 
host‟s inflammatory response (Collier et al., 2008).   
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Interleukin -1β 
Interleukin-1β, a pro-inflammatory cytokine produced by macrophages, 
endothelial cells, and epithelial cells, mediates the inflammatory response of the host.  
The level of response or inflammation depends on the amount of IL-1β produced.  Small 
quantities result in local inflammation.  Large concentrations of IL-1β enter the blood 
stream, stimulate the synthesis of acute phase plasma proteins as part of the early innate 
immune response, and stimulate the production of IL-6, which promotes the growth of 
B-lymphocytes (Abbass et al., 2007) in addition to increasing chemokine and 
corticosterone production (Hilton et al., 2002).  Although IL-1β appears to have a similar 
function in birds as it does in mammals, the location of genetic loci on the chromosome 
is not similar to the mammalian analogue (Abbass et al., 2007).  Quantitative real time 
polymerase chain reaction (qRT-PCR) analysis has shown an 80-fold increase in IL-1β 
gene expression seven days after a challenge with Eimeria tenella in the chicken.  
Similarly, challenges with Eimeria maxima tend to up regulate IL-1β gene expression 
but to a much lesser extent (Kaiser et al., 2004). 
 
Gene Expression 
 Gene expression profiling of immune related components, such as cytokines and 
Toll-like receptors, throughout the course of infections may provide insight to 
controlling particular diseases (Abasht et al., 2008).  The characterization of mucosal 
immune related genes in the chicken is to some extent focused on responses to infections 
with Salmonella, although limited data concerning coccidial infections in the chicken is 
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available.  Mucosal gene profiling in the turkey is absent in the peer reviewed literature.  
Gene expression can be measured by extracting the mRNA in the biological sample, 
amplified with probes and primers, and quantified using qRT-PCR (Roth, 2002).  
Reference endogenous genes, such as glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) are used as standards for changes in gene expression (Zhou et al., 2010).  Fold 
changes in mRNA gene expression can be calculated using the described 2
-ΔΔ
 
CT
 method 
for gene expression data acquired using qRT-PCR (Livak and Schmittgen 2001). 
Based previous research of the Toll-like receptor mRNA expression in the 
duodenum and cecal tonsils, native breeds of chickens in India are immunologically 
more competent and disease resistant than the commercial equivalent (Dhinakar Raj et 
al., 2009).  The selection for increased performance, such as growth, has resulted in 
adverse effects on the immune response (van Hemert et al., 2006; Dhinakar Raj et al., 
2009).  Similarly, distinct differences in immune responses are seen between fast and 
slow growing lines of broilers in the jejunum when they are challenged with Salmonella 
(van Hemert et al., 2006).  The faster growing line responded to the challenge with an 
increase in genes that enhance T cell activation while the slower growing strain 
responded differently and more efficiently.  The slower strain had an increase in 
macrophage activation.  The different immune responses exhibited between the fast and 
slow growing broiler lines to the same pathogen may potentially explain the variations in 
susceptibly to Salmonella (van Hemert et al., 2006).  The continuous investigation of 
gene expression in the chicken, regardless of the pathogen, provides a fundamental 
foundation to the study of gene expression and immune response in the turkey.  
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Anticoccidial Drugs 
The first anti-coccidial chemotherapeutic drugs appeared on the market in 1939 
(Long, 1984).  Initially sulphonamide, sulphanilamide, and sulphodium iodine were used 
to treat the disease and sulphaquinoxaline and nitrophenide were used in the prevention 
of the disease.  Sulpha-based chemicals inhibit meront development and the sexual 
stages of development.  The heavy use of sulpha-based chemicals led to widespread 
Eimeria resistance.  Nitrobenziamides were heavily used in the 1960‟s and 1970‟s until 
species of Eimeria acquired resistance to the chemicals and were no longer effective.  
Amprolium has been used since the 1960‟s and reports of Eimeria resistance exists 
(Long, 1984).  Monensin, an ionophorous antibiotic, is one of the most widely used 
anticoccidial drug in turkeys operations, approximately in 70% of all meat-type turkeys 
(Chapman and Rathinam, 2007).  The majority of field isolates are now fully or partially 
resistant to monensin (Chapman and Rathinam, 2007).  Ionophores disrupt the normal 
ionic gradients of the coccidia by creating hydrophilic channels or by transporting ions 
across the lipid bi-layer.  The gradient change results in mitochondrial damage and 
subsequently a lack of cellular energy.  The lack of energy inhibits the transport of 
sodium and potassium ions across the surface membrane, which is critical for normal 
cellular function.  Due to the nature of the chemical, ionophores easily accumulate in the 
host‟s tissue, which leads to a very narrow margin of safety (Long, 1984; Kart and 
Bilgili, 2008).  Ionophore toxicity reports of ataxia, reduced performance, paralysis, and 
death occur frequently in turkeys because of cardiac muscle damage and myelin 
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degeneration of the nervous system induced by the ionophore (Mathis, 1993 and Kart 
and Bilgili, 2008).   
The use of anticoccidials may interfere with the development of immunity and 
delay coccidial protection (Karlson and Ried, 1978; Yadav and Gupta, 2007), although 
the overall effect on immunity is disputed (Hu et al., 2000).  The second-generation 
schizont is needed to induce a proper immune response but the majority of ionophores 
tend to stop the coccidial life cycle at the first generation schizont (Yadav and Gupta, 
2007).  Since various types of chemicals act on different stages of the Eimeria life cycle, 
immunity is linked to the type of anticoccidial used (Mathis, 1993).  Halofuginone 
significantly suppresses the amount of shedding and recycling of oocysts and when 
removed from the diet between eight to ten weeks of age coccidiosis breaks may occur 
(Mathis, 1993).  Yadev and Gupta (2007) indicated that different isolates of the same 
strain affected the immune development differently.  The type of litter used also has an 
effect on immune development.  Unmedicated chicks raised on used litter acquire 
immunity by five weeks of age, due to natural exposure from oocysts shed in the 
previous flock, compared to the typical seven weeks when chicks are raised on new 
litter.  Medicated chicks acquire immunity by seven week regardless of the type of litter 
used (Chapman, 1999).  A single large peak of oocysts occurs in the litter of chicken 
flocks between four and eight weeks of age when fed a preventative dose of ionophores 
in the diet (Williams, 1998). 
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Advantages/Disadvantages 
Performance in medicated flocks is consistently equal to or better than those that 
are vaccinated (Danforth, 1998).  Medicated flocks tend to have significantly higher 
body weights and better feed conversion rates than vaccinated flocks (Li et al., 2005; 
Rojs et al., 2007).  In addition to being an anticoccidial, ionophorous antibiotics have 
additional benefits unrelated to Eimeria.  Salinomycin has a positive effect on the 
microflora in the gastrointestinal tract in broilers.  It decreases the amount of Clostridia 
perfringens in the gastrointestinal tract and reduces the risk and incidence of necrotic 
enteritis in broilers (Johansen et al., 2007).  Since ionophores are antimicrobial 
compounds, they reduce the overall bacterial load in the gut and increase feed efficiency, 
consequently they are classified as growth promoters.  Medicated birds also have higher 
body weights than non-medicated unchallenged controls (Johansen et al., 2007). 
Although there are benefits to using prophylactic treatments, there are several 
reasons for discontinuing their use.  Foremost, Eimeria species easily develop resistance 
to chemicals and ionophorus antibiotics (Li et al., 2004).  In recent field study conducted 
by Chapman and Rathinam (2007), the majority of field isolates of Eimeria in 
commercial turkey operations were either partially or fully resistant to monensin.  The 
growing demand for naturally raised poultry products and increasing chemical resistance 
has fueled the need to find alternative methods to prophylactic treatments for the control 
of coccidiosis.   
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Vaccines 
Traditional Vaccines 
Coccidiosis vaccines are nearly 60 years in the making.  Professor Samuel Allen 
Edgar of Auburn University, Auburn, Alabama successfully formulated the first 
anticoccidial vaccine in 1952 for chickens (Williams, 2002).  The vaccine consisted of a 
single live virulent strain of Eimeria tenella and was marketed under as what is known 
today as Coccivac®.  Dr. Eng-Hong Lee created and marketed the next live non-
attenuated vaccine for chickens known as Immucox® (Vetech Laboratories Inc., Guelph, 
Ontario)  in Canada in 1985 (Williams, 2002).  Paracox®, a combination of live 
attenuated strains, was developed in 1989 in the Netherlands as part of the Glaxco 
Animal Health Ltd® (Williams, 2002).  Attenuated strains are selected based on the 
precocious trait that is very stable and heritable.  Precocious strains have a decreased 
reproductive potential yet have the ability to stimulate immunity while causing minimal 
damage to the gastrointestinal tract.  Precocious strains can interbreed with 
corresponding wild species and reduce the virulence of the wild strain (Williams, 1998).  
Dr. Peter Bedrnik of the Czech Republic formulated Livacox® (Virbac Animal Health, 
Republic of South Africa), the first vaccine that contained embryo adapted attenuated 
species of Eimeria, in 1992 (Williams, 2002).  It was not until 1989 that the first 
coccidial turkey vaccine, Coccivac-T®, became available.  All live vaccines 
commercially available today were derived from of Coccivac®, Paracox®, or Livacox® 
formulations (Williams, 2002).  Nearly 60 years later coccidial vaccines appear to 
remain effective, decreased efficacy of the vaccines has not been reported.  The use of 
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vaccines has restored the sensitivity of Eimeria to in feed coccidiostats and has replaced 
virulent field strains in the environment by competitive exclusion (Williams, 1998). 
Coccidial vaccines are administered to poults during the first week of life via a 
gel drip (Immucox®) or water based spray (Coccivac-T®).  Coccivac-T® administered 
to day old turkey poults via ocular vaccination provides similar protection as oral 
ingestion of the oocyst (Chapman, 1996).  Proper administration of the vaccine is critical 
for its effectiveness (Williams, 1998), uniform vaccination results in even immune 
development in the flock.  Gel applications tend to keep the oocysts suspended more 
evenly in solution than water based sprays that require the assistance of an aerator and 
based on lesion scores, result in a more uniform vaccination based on lesion scores 
(Dasgupta and Lee, 2000).  To acquire immunity to species of Eimeria in the chick, the 
vaccine must result in a low-level coccidial infection with several cycles of oocyst 
shedding and re-infection (Li et al., 2004).  Coccidial cycling can be determined by 
enumerating the oocysts shed in the fecal droppings and the litter.  Fecal samples reflect 
the intensity of the coccidial infection at that specific time while litter samples tend to 
evaluate the accumulation of oocysts in the litter and even out small-scale peaks seen in 
fecal samples (Williams, 1998).  Approximately one week following the vaccination of 
the chicken with Paracox®, oocysts start to appear in the litter.  Between the second and 
fourth week, a small peak in oocyst shedding is seen (Williams, 1998).  Between the 
fourth and seventh week post vaccination a slightly higher peak is normally seen.  The 
second higher peak is most likely due to a field challenge (Williams, 1998).  Oocyst 
recycling and shedding tends to decrease as host immunity increases.  Approximately 
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seven to eight weeks post vaccination very few oocysts are detected in the litter.  All 
vaccinated chicken flocks exhibit similar oocyst shedding patterns (Williams, 1998). 
An added coccidiosis vaccination practice in the commercial egg laying industry 
demonstrates the importance of the recycling and re-exposure of oocysts to acquire full 
immunity (Soares et al., 2004).  Hens raised in wire cages had limited exposure to their 
feces or shed oocysts.  Prior to the placement of paper plates in the cages for a period of 
two weeks following vaccination, to promote the recycling of oocysts, vaccinated laying 
hens were not able to acquire immunity to Eimeria and coccidiosis breaks were 
common.  After adopting the paper plate method, hens developed immunity much 
quicker and exhibited overall increases in egg production (Soares et al., 2004). 
 
Non-traditional Vaccines 
In ovo vaccination is a fairly new technique that is being attempted as an 
alternative administration method.  Under experimental conditions, broiler chicks 
vaccinated with sporozoites, sporocycts, or oocysts via in ovo injection in the air cell on 
the eighteenth day of incubation shed oocysts in their feces post hatch (Weber and 
Evans, 2003).  In ovo vaccinated chicks had lower lesion scores compared to the controls 
and exhibited coccidial protection when experimentally challenged at three weeks of age 
(Weber and Evans, 2003).  Inovocox® (Pfizer Animal Health, Durham, NC), the only 
commercially in ovo anticoccidial vaccine available, is comprised of chicken species of 
sporulated oocysts (Dalloul and Lillehoj, 2005).  Future in ovo vaccines may consist of 
sporocytes that are injected directly into the yolk (Vermeulen et al., 2001).   
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Sub-unit vaccines are antigen based and not capable of replicating in the host 
making the risk of adverse reactions relatively low (Abbass et al., 2007).  Eimeria 
tenella sporozoite antigens incorporated into immune stimulating complexes (ISCOM), a 
vaccine adjuvant, and administered intranasally induced protection under experimental 
conditions.  Vaccinated chicks challenged with Eimeria tenella had lower lesion scores, 
a lesser amount of tissue damage, and a smaller amount oocyst shedding when compared 
to unvaccinated controls (Garcia et al., 2008).  CoxAbic® (ABIC Biological 
Laboratories Teva Ltd., Israel), recently developed in Israel to control chicken 
coccidiosis, is the only sub-unit anticoccidial vaccine commercially available.  It is a 
transmission blocking vaccine that consists of affinity-purified gametocyte antigens 
which inhibit the development of macrogametes into oocysts.  Vaccinated hens pass 
maternal antibodies to Eimeria to the offspring.  CoxAbic® has been tested on over 60 
million broiler offspring throughout Asia, Africa, Eastern Europe, and Latin America, 
and is effective in controlling coccidiosis (Sharman et al., 2010).   
Recombinant vaccines, a type of sub-unit vaccine, may be less expensive to 
manufacture and have a longer shelf life than the traditional live vaccines (McDonald 
and Shirley, 2009).  Sub-unit vaccines may be dosed by injection and therefore result in 
a more consistent exposure.  Since recombinant vaccines do not require recycling of 
oocysts to gain immunity, adverse side effects of traditional live vaccines could be 
avoided (Vermeulen et. al, 2001; Williams, 2002; Talebi and Mulcahy, 2005; McDonald 
and Shirley, 2009).  Salmonella typhimurium and herpes virus of the turkey (HVT) are 
potential vaccine vectors for Eimeria antigens derived from invasion proteins on the 
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sporozoites or from the asexual and sexual stages of the life cycle (Vermeulen, 1998).  
Antigen based vaccines elicit a humoral antibody response but do not elicit the local IgA 
mediated immune response in the mucosa of the gastrointestinal tract.  Therefore, local 
mucosal immunity is not acquired when birds are vaccinated with antigen-based 
vaccines (Long, 1984).   
In addition to sub-unit vaccines, synthetic peptides containing T and B cell 
epitopes have been shown to elicit a significant humoral response and induce the 
proliferation of lymphocytes.  Cross-protection between species of Eimeria may be 
possible with synthetic peptide vaccines (Talebi and Mulcahy, 2005).  Short 
oligodeoxynucleotides containing unmethylated cytosine-phosphate-guanine (CpG) 
motifs also stimulate innate and adaptive immune responses by enhancing antigen-
presenting cells and supporting Th1 responses.  In ovo vaccination of CpG in white 
leghorn chickens improved weight gain and reduced oocyst shedding when birds were 
challenged with Eimeria tenella (Dalloul et al., 2005).  Similarly, injections with the 
chicken cytokine IFN-γ reduced oocyst production and the negative effects coccidiosis 
had on growth performance (Lowenthal et al., 2000).  
 
Problems with Vaccination 
As promising as coccidiosis vaccines seem, they are not widely accepted for a 
number of reasons.  Consistent uniform vaccination is difficult to obtain since the 
majority of traditional vaccines are administered orally (Dasgupta and Lee, 2000).  
Pecking order as well as hatch timing can affect vaccine uptake (unpublished).  Uniform 
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distribution of vaccine oocysts is critical for the uniform development of immunity in a 
flock.  Uneven oocyst distribution may lead to uneven recycling of oocysts.  Unprotected 
birds may ingest a high or lethal dose of oocysts when they are shed in the droppings of 
vaccinated birds and result in uneven flock uniformity (Dasgupta and Lee, 2000).  
Higher doses of oocysts are associated with decreased growth (Hu et al., 2000).  
Therefore, birds that are over exposed during vaccination may also exhibit adverse 
results.  Stressors or immunosuppressive diseases may interfere with the necessary 
vaccine induced immune response and inhibit immunity to Eimeria (Williams, 1998).  
There have been several contradictory reports regarding bird performance after 
vaccination.  Body weight and feed conversion rates in vaccinated chicks are not always 
equivalent to birds treated with prophylactic medications (Danforth, 1998).  Although 
mortality appears to be similar (Rojs et al., 2007), several reports indicate that both 
vaccinated chicks and poults exhibit a post vaccinal set back in weight gain (Chapman, 
1996; Danforth, 1998; Williams, 1998).  Some researchers suggest that the set back in 
weight gain cannot be compensated for (Williams, 1998), while other reports suggest 
that vaccinated birds exhibit compensatory growth and comparable in weight to 
unvaccinated and unmediated controls at the time of market (Danforth, 1998; Li et al., 
2005).  Poults vaccinated via ocular administration exhibited suppression in weight gain.  
At three weeks of age, vaccinated poults had significantly lower body weights than the 
unchallenged controls.  At six weeks of age, there were no significant differences in 
body weight (Chapman, 1996).  Production costs in vaccinated and medicated birds 
appear to be similar (Lee et al., 2009).  
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Vaccines used in conjunction with other programs may provide additional 
benefits.  Live attenuated multi-valent monensin tolerant vaccines used in conjunction 
with monensin showed beneficial results.  This combination helps protect young birds 
from virulent field strains of Eimeria when immunity has not developed during the first 
three to four weeks, to decrease the spread of virulent field strains, and increase weight 
gain (Li et al., 2004 and Li et al., 2005).   
 
Alternative Treatments 
Consumer demands for organically grown poultry and concerns regarding 
bacterial resistance have led to the exploration of natural treatments to the prophylactic 
use of chemicals.  Essential oils, classified as residue free, secondary plant metabolites 
are currently the subject of several investigations.  Certain essential oils exhibit 
antimicrobial, antioxidant, and antiparasitic properties (Brenes and Roura, 2010).  They 
also have a positive impact on the microbial communities in the gastrointestinal tract that 
is important for the development of immunity to pathogens (Oviedo-Rondon et al., 
2006).  Several factors can affect microbial communities such as feed quality, feed 
additives, or even the use of coccidiosis vaccines.  Coccidial challenges drastically shift 
microbial communities in the gastrointestinal tract.  The use of essential oil blends helps 
avoid the drastic shift in microbial communities typically seen with coccidal challenges 
(Hume, 2006; Oviedo-Rondon et al., 2006).   
Oregano supplements in the diet have some anticoccidial effects in the chicken 
but are much lower when compared to the ionophore lasalocid (Giannenas et al., 2003).  
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Similar results were seen with Apacox® (GreenVet® Veterinary Phytotherapy, Italy); a 
commercial blend of herbal extracts (Christaki et al., 2004).  When Orego-Stim® 
(Meridian Animal Health Ltd., Bedfordshire, UK), a commercially available oregano 
based product, was used in conjunction with the coccidiosis vaccine, Paracox® in the 
chicken, increased body weight and decreased feed conversion rates were seen 
(Waldenstedt, 2003).  Direct-fed microbials also affect microbial communities.  Direct-
fed microbials act as immunomodulating agents and increase the protective immune 
responses of both the innate and acquired immune systems.  Immunity to Eimeria is 
increased with direct-fed microbials due to the elevation in cell-mediated immunity.  
Chicks fed direct-fed microbials exhibited fewer clinical signs, reduced lesion scores, 
and increased in body weight when challenged with species of Eimeria (Lee et al., 
2010).                
The crude extract of the guava leaf acts is a coccidiostat.  Body weight, feed 
conversion rate, mortality, and carcass quality of broilers fed diets containing guava leaf 
extract at levels as low as 0.04% are comparable to broilers vaccinated with CocciVac 
B®, LivaCox D®, or fed the coccidiostat Avatec® (Alpharma®, Mississauga, Ontario) 
(Rattanaphol, 2009).  Yucca schidigera extract, the Mojave yucca, also acts as a 
coccidiostat.  The natural saponin affects the cholesterol on cell membranes of the 
protozoa and inhibits the development of coccidia.  The Mojave yucca has a synergistic 
relationship with anticoccidial vaccines.  Vaccinated birds fed diets containing yucca 
extract have longer duodenal villi and better feed conversion rates when compared to the 
controls, birds solely vaccinated, solely fed a coccidiostat, or fed the coccidiostat and the 
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extract (Alfaro et al., 2007).  Diets containing flaxseed or high levels of n-3 fatty acids 
offered some protection against particular strains of Eimeria in the chicken via reduction 
of oxidative stress.  Eimeria tenella, characteristically reproduced in the anaerobic 
environment of the ceca, may be susceptible to oxidative stress.  Diets containing high 
levels of n-3 fatty acids suppressed the development of Eimeria tenella in the ceca but 
had no obvious beneficial effect on the development of Eimeria maxima in the mid 
intestine (Allen et al., 1997).    
 
Conclusion 
Coccidiosis is the most expensive disease in the poultry industry (Dalloul and 
Lillehoj, 2006).  Intensive rearing systems favor species of Eimeria (Long, 1984) and the 
oocyst stage of the life cycle make it very resistant to drying and chemicals, allowing it 
to survive in the environment for extended periods of time (Saif, 2003).  Typically, the 
use of anticoccidial medications have been favored over the use of coccidiosis vaccines 
to control the disease due to differences in performance related to post-vaccinal 
reductions in weight gain (Chapman, 1996; Danforth, 1998; Williams, 1998).  The 
majority of field turkey isolates of Eimeria are fully or partially resistant to the 
commonly used ionophore monensin due to overuse (Chapman and Rathinam, 2007).  
Increased chemical resistance and demand for naturally raised poultry products are 
forcing the decrease in use of anticoccidials.  The role vaccination in the control of 
chicken coccidiosis has been studied but its role in turkeys is not yet described in the 
literature.  In addition to the need for further anticoccidial vaccine research in the turkey, 
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there is an increased need for the understanding of the turkey‟s immune response.  The 
study of immune related mucosal gene expression in the gut may provide information to 
the host‟s response and give a better insight to controlling the disease as well as others 
(Abasht et al., 2008).   
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CHAPTER III 
COCCIDIOSIS VACCINE INDUCED OOCYST SHEDDING PATTERNS 
 
Overview 
 Vaccine induced oocyst shedding patterns in turkey poults vaccinated on day of 
hatch with Coccivac-T® (Intervet/Schering-Plough Animal Health, Summit, NJ) was 
investigated.  One hundred Hybrid® (Ontario, Canada) turkey hens were gavaged with a 
single dose of vaccine, 0.28 mL, randomized into four identical groups, and raised on 
wood shavings under experimental conditions for 30 days.  Three fecal and three litter 
samples were obtained from each group, on a daily basis, analyzed, and compared.  
Body weights from five random poults in each group were taken on a weekly basis.   
The fecal sampling provided more accurate and sensitive information when 
compared to the litter sampling.  The litter samples were highly variable depending upon 
the location of the pen sampled.  Based on fecal samples, peaks in vaccine oocyst 
shedding occurred on 5-6, 13- 17, and 19-20 days post vaccination.  Gross lesions and 
clinical signs such as huddling, lethargic birds, and bloody droppings coincided with 
peak oocyst shedding days.  Vaccine shedding trends and body weights were similar 
amongst all four groups.  Weekly body weights and rate of gain correlated with vaccine 
cycling observed in fecal samples.     
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Introduction 
Avian coccidiosis, caused by infections with species of the intestinal parasite 
Eimeria, is a universal problem in the poultry industry.  The disease most notably 
characterized by diarrhea and enteritis is the most expensive disease affecting the poultry 
industry today.  Treatment costs and lost performance total an estimated $3 billion 
dollars each year worldwide (Dalloul and Lillehoj, 2006).  Traditionally, the poultry 
industry has relied heavily on the use of coccidiostats to prevent or treat the disease 
(William, 2002).  Unfortunately, species of Eimeria easily develop resistance to 
chemicals and antibiotics making them less effective for long-term treatment (Li et al., 
2004).  A recent field study conducted by Chapman and Rathinam (2007) revealed the 
majority of turkey strains of Eimeria are either partially or fully resistant to the 
commonly used ionophore, monensin.  The growing demand for naturally raised poultry 
products, and increasing chemical resistance has fueled the need to find alternative 
methods to prophylactic treatments for the control of coccidiosis.  Consequently, 
intensive rearing systems favor the Eimeria life cycle (Long, 1984) therefore the threat 
of coccidiosis is unlikely to disappear.   
Eimeria are single-cell obligate intracellular parasites with a complex life cycle 
consisting of both asexual and sexual stages.  Species of Eimeria are host specific and 
seven species infect the turkey.  Of the seven, four of them are considered pathogenic or 
of economic importance: Eimeria meleagrimitis, Eimeria dispersa, Eimeria 
gallapovonis, and Eimeria adenoeides (Saif, 2003; Charlton, 2006).  Coccivac-T®, one 
of the two live coccidial vaccines commercially available for the turkey, contains 
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oocysts from all four pathogenic strains of Eimeria.  Coccidiosis vaccination in the 
turkey is relatively new when compared to the chicken.  The first anticoccidal turkey 
vaccine, Coccivac-T®, appeared 21 years ago while the first chicken vaccine appeared 
nearly 60 years ago (Williams, 2002).  Although vaccines appear to be a viable 
alternative to prophylactic treatment, side effects such as post-vaccinal setbacks in 
weight gain have limited their acceptance (Danforth, 1998) even though reports of 
compensatory growth exist in the chicken (Danforth, 1998 and Li et al., 2005).  Reports 
also indicate that medicated flocks consistently have significantly higher body weights 
and lower feed conversion rates than vaccinated flocks (Danforth, 1998; Li et al., 2005; 
Johansen et al., 2007; Rojs et al., 2007).  There is a lack of peer-reviewed data regarding 
coccidiosis vaccination in turkeys.  Coccivac-T® is typically applied at the hatchery via 
a spray cabinet.  A 10,000-dose vial of the vaccine is mixed with 280 mL of water and 
aerated to keep oocysts suspended in solution (Coccivac-T® Instructions).  Green dye is 
added to the vaccine to promote preening and oocyst ingestion.  Hydration levels and 
pecking order may affect uptake and lead to uneven exposure.  Initial uneven vaccine 
exposure may result in adverse growth effects or mortality in the brooder barn (Dasgupta 
and Lee, 2000).   
The progression of the coccidiosis and its characteristics between the chicken and 
the turkey are somewhat different therefore, data acquired in the chicken is not fully 
applicable to the turkey.  Different species of Eimeria infect the turkey than the chicken 
and the coccidial life cycle is shorter.  Although coccidiosis is very common in the 
turkey industry, the disease often times goes undiagnosed (Saif, 2003).  Diagnosis is 
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difficult because species of Eimeria that infect the turkey do not infiltrate the intestinal 
wall very deeply.  Intestinal lesions heal very quickly and are often times missed upon 
necropsy when clinical signs are observed (Saif, 2003).   
The objective of this trial was to examine vaccine induced oocyst shedding 
patterns in turkey poults gavaged with a single dose of Coccivac-T® on day of hatch.  
Shedding patterns were studied through the daily monitoring and enumeration of oocysts 
in fecal and litter samples.  The goal was to characterize vaccine oocyst shedding 
patterns for the subsequent lesion and immune response trials.  To understand and isolate 
vaccine specific characteristics, poults were grown under experimental conditions.   
 
Materials and Methods 
Experimental Design  
 The experiment was set up as a time course study with four identical treatment 
groups.  One-hundred newly hatched Hybrid hen poults from a recycled Willmar Poultry 
Company breeder flock thirteen weeks into production were obtained from Willmar 
Poultry Company Hatchery (Willmar, Minnesota).  Poults were serviced according to 
routine hatchery procedures and randomized into four replicate groups of 25 birds.  
Average poult weight per group ranged from 60 to 65 grams.  One vial of Coccivac-T ® 
(TCV-4) (Serial Number 94380002) provided by Intervet/Schering-Plough Animal 
Health was mixed according to the manufacturers‟ specification by mixing a 10,000 dose 
vial with 280 mL of distilled water and five mL of green dye.  To ensure uniform dosing, 
each bird was gavaged with 0.28 mL of vaccine solution.  Based on hemocytometer 
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counts, 0.28 mL of vaccine mixture contained approximately 500 oocysts.  According to 
the specifications, Coccivac-T® vaccine contained live oocysts from Eimeria 
adenoeides, Eimeria meleagrimitis, Eimeria gallopavonis, and Eimeria dispersa.  
Before poults were placed, three litter samples were obtained from each pen.  
Poults were housed in individual group pens in an isolation brooder room on wood 
shavings.  The pen number represented the group number.  The pen set up was similar to 
that typically seen in commercial turkey operations, for example, birds were confined to 
small cardboard rings placed under the brooder stove for the first days in addition to 
close access to feed and water.  On day six post hatch each group was let out of the 
cardboard rings into a larger individual group pen.  There was approximately 0.85 square 
feet per bird.  Feed and water was available ad libitum.  Poults were fed a (Nutrena 
Naturewise® Gamebird Starter Crumbs 91183 NR 0504, Runnings, Willmar, MN) non-
medicated ration consisting of 27% crude protein.  Body weights from five random birds 
per group were taken on a weekly basis for four weeks.  Three 10 g litter samples were 
randomly obtained from the top inch of the litter in each pen on a daily basis for 30 days 
and stored in Whirl-pak® bags at 4°C until processed.  In addition to the litter samples, 
three 4 g fecal samples were obtained daily for 30 days and stored in the same manner as 
the litter samples.  The study was conducted using Willmar Poultry Company dba Ag 
Forte animal welfare guidelines.    
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Determination of Oocysts in Fecal Samples 
The number of oocysts shed in the fecal droppings was determined by using a 
protocol provided by Dr. Steve Fitz-Coy from Intervet/Schering-Plough Animal Health 
(personal communication).  The 4 g fecal sample was homogenized thoroughly by hand 
in the Whirl-pak® (Nasco®, Salida, CA) bag.  Twelve mL of double distilled water was 
added to the bag and the sample was homogenized again.  Once the fecal material was 
uniformly suspended in the water, 10 µL of the suspension was removed from the bag 
and both chambers of a hemocytometer were loaded.  Oocysts found in the large center 
square and four large corner squares of each of the chambers were counted.  The 
hemocytometer was then cleaned and reloaded with the next sample.  Four chambers 
were counted per sample.  Samples that had very high concentrations of oocysts were 
diluted with an additional 12 mL of reverse osmosis water to allow more accurate 
counting.  The amount of oocyst per gram of fecal material was calculated according the 
respective dilutions.   
 
Determination of Oocyst Shedding in Litter Samples 
Oocyst shedding patterns in the litter were determined using the method 
published by Pfizer Animal Health in “Poultry Coccidiosis- Diagnostic and Testing 
Procedures” (Conway et al, 1991).  One-hundred mL of tap water was added to the 10 g 
litter sample in the Whirl-pak® bag.  The sample was homogenized by hand until 
thoroughly mixed and allowed to soak for 24 hours at 4°C.  The Whirl-pak® bag was 
then shaken vigorously to thoroughly mix the contents and filtered through a single layer 
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of cheesecloth into a beaker.  Fifteen mL of filtrate was poured off into a centrifuge tube 
and then centrifuged at 5,000 rpm for five minutes and the superntant was decanted. The 
solid pellet at the bottom of the tube was re-suspended in three mL of saturated sodium 
chloride salt solution using a vortex.  After the pellet was re-suspended, additional 
saturated salt solution was added to the test tube to equal 15 mL of litter solution.  In 
order to maintain sample consistency, the test tube was inverted 10 times before the sub-
sample was removed.  A two-chambered McMaster egg counting slide was charged with 
the litter solution.  The slide sat for one minute prior to reading to allow the oocysts to 
float to the top of the solution and all oocysts within the grid of each chamber were 
counted.  The McMaster slide was rinsed thoroughly with tap water between samples.  
Oocysts per gram of litter were calculated according to the published protocol.  
 
Statistical Analysis 
 Statistical analysis to determine if pens differed in body weight was performed 
using a one-way ANOVA test with SPSS® Graduate Pack 16.0 for Windows Software 
(SPSS® Inc, Somers, NY).  Differences in the mean body weights between the groups 
were considered to be significant if probability (P)-values were<0.05. Error bars on the 
graphs are at a 95% confidence interval.  
 
Results and Discussion 
One-day post hatch vaccination, the droppings of the birds in the litter appeared 
green most likely due to the dye used in the vaccine.  Examination of the droppings 
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revealed a large amount of degraded oocysts and or ruptured oocysts in addition to a few 
sporulated oocysts.  According to Williams (1998), up to 20% of ingested oocysts can 
pass through the gastrointestinal tract undamaged.  On day seven, some birds started to 
exhibit some ruffled feathers.  On day nine, trace amounts of blood were seen in the 
fecal droppings in pen number three.  On day 10, blood started to appear in the 
droppings of pens number one and four.  On day 14, there were trace amounts of blood 
in the droppings of all groups.  The amount of blood in the droppings increased through 
day 17.  On day 17, several birds in each pen exhibited clinical signs of coccidiosis.  
They were hunched over and the heat in the rooms needed to be increased two degrees to 
make the birds comfortable, possibly indicating hypothermia or fever in response to the 
infection.  Pens three and four had trace amounts of blood in the feces on day 18.  Pens 
one and two had trace amounts of blood in the droppings on day 20.  The amount of 
blood in the droppings appeared to peak again at day 21.  Again, a few birds appeared 
lethargic with ruffled feathers.  After the 22 day, the birds appeared to thrive, the 
presence of blood in the droppings was less frequent, and oocyst cycling appeared 
decrease drastically.  The unevenness in the onset of symptoms between pens correlates 
with the slight variability in oocyst shedding patterns seen.  This is likely due to the 
coprophagic nature of individual pens.  All lethargic and sick birds recovered and the 30-
day livability was 100%, similar with observations by Rojs et al. (2007).  Since poults 
were gavaged with the vaccine, exposure level was likely higher.  Clinical symptoms 
may have been as a result of a higher vaccine exposure 
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Oocyst Shedding via Fecal Sampling  
 To obtain a more accurate idea of oocycst shedding in the fecal droppings, 
samples were run in duplicate.  Samples were averaged to obtain daily oocyst output for 
each individual pen.  Fecal samples reflect the intensity of the coccidial infection at a 
specific point in time (Williams, 1998).  Oocyst shedding patterns for individual pens 
followed a similar trend with slight individual pen variations (Fig. 1).  When all pens 
were averaged, there were three distinct peaks at days 5-6, 13-17 and 19-20 post 
vaccination (Fig 2). 
 
 
 
Figure 1.  Mean daily OPG fecal by pen.  
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Figure 2 .  Combined mean daily OPG fecal.  
 
The average number of days in a life cycle of Coccivac-T® appeared to be 
approximately five days.  This is shorter than the typical seven day cycling pattern seen 
in the chicken.  There was a slight increase in oocyst shedding at around day 10.  This 
peak is most likely lower and or delayed because the birds were released from the 
cardboard rings on day six.  The rings were expanded during the first peak in shedding 
and oocyst exposure and uptake was somewhat limited.  Oocyst shedding was shown to 
be influenced by management practices.  Different management practices may 
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potentially affect efficacy of the vaccine.  A uniform peak between pens was seen 
following the controlled gavaged dose.  Thereafter, there was a slight variation in 
shedding patterns due to the coprophagic behavior of the individual pen (Fig. 1).  
Nonetheless, each of the four pens followed a similar vaccinal oocyst shedding pattern.   
 
Oocyst Shedding via Litter Sampling  
 Mean daily oocyst per gram of litter by pen was highly variable (Fig. 3).  When 
all pens were averaged throughout the study, oocyst shedding patterns appeared 
somewhat similar to the patterns seen in the fecal samples (Fig. 4).  The litter samples 
were more variable and less sensitive than the fecal samples.  This is consistent with 
what Williams (1998) described about litter samples.  Litter sampling minimizes small 
scale peaks often times seen in fecal samples and tends to measure oocyst accumulation 
in litter rather than the intensity of the coccidial infection (Williams, 1998).  There is 
more variability in litter samples depending upon where the sample is collected.  
Naturally, oocyst concentrations were higher where birds tended to migrate, such as the 
feeders and drinkers, compared to the edges of the ring therfore multiple samples need to 
be obtained to correlate with fecal sampling.  Smaller scale peaks seen in the litter 
samples after day 20 were most likely from birds that may still have been cycling.  
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Figure 3.  Mean daily OPG litter by pen. 
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Figure 4.  Combined mean daily OPG litter. 
 
Body weight trends and oocyst cycling were correlated.  After the week three 
body weights, rate of growth increased two to three times of what it was week two to 
week three  (Fig. 5).  Based on fecal oocyst counts, oocyst shedding dropped 
dramatically the third week.  The birds appeared to exhibit an increase in growth during 
the third and fourth week post vaccination.  It is unknown if this is a normal growth 
curve or a form of compensatory growth.  Chapman (1996), Danforth (1998), Williams 
(1998), and Li et al. (2005) described a post-vaccinal set back in weight gain with 
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coccidiosis vaccinations.  Long-term setbacks in weight gain (Williams, 1998) as well as 
compensatory growth in vaccinated birds (Danforth, 1998; Li et al., 2005) have been 
reported.  Differences in body weight between pens were not observed.  (Fig. 5)   
 
 
Figure 5.  Average weekly body weight by pen. 
 
There is a general lack of information describing the role vaccinations have in the 
control of turkey coccidiosis.  This is the first paper to investigate the coccidiosis 
vaccine oocyst shedding patterns and gross observations of coccidiosis vaccination in the 
turkey in detail.  A better understanding of the disease characteristics in the turkey and 
potential control measures such as coccidiosis vaccines may provide an explanation to 
observations seen in the field and better ways to manage vaccinated flocks.  The results 
of this trial are the basis for subsequent lesion and immune response studies.  
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CHAPTER IV 
COCCIDIOSIS VACCINE INDUCED LESIONS AND MUCOSAL GENE 
EXPRESSION OF IL-10 AND IL-1β 
 
Overview 
Coccidiosis vaccine dose and its effects on body weight, histological lesions, and 
mucosal gene expression of turkey poults vaccinated on the day of hatch were 
investigated.  Poults were gavaged with a 0.28 mL solution containing the equivalent to 
either 0 x, 0.5 x, 1 x, or 2 x manufacturers available dose of vaccine oocysts and raised 
on wood shavings under isolation conditions.  During times of peak vaccine oocyst 
shedding, determined in a previous study, poults were sacrificed, weighed, and three 
areas of the gastrointestinal tract were collected.  A two cm section of intestine centered 
over the Meckel‟s diverticulum, the ileocecal junction, and the middle of the ceca were 
collected for histological examination.  An approximate 0.4 g sample of adjacent tissue 
was obtained from each section for gene expression analysis.  Histological 
measurements from the tip of the villus extending down to the base of the lamina 
propria, width of the villus, and muscularis mucosae thickness were taken using 
imaging software.  Body weight and oocyst dose were inversely related.  Significant 
differences with regards to the intestinal measurements and dose response were seen but 
the results were not always linear.  A significant variation among individuals within the 
same group was seen, therefore limiting statistical data.  Mucosal gene expression of IL-
10, IL-1β, and GAPDH was examined in the control group and twofold vaccine dosed 
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group.  Analysis of the genes was obtained through mRNA extraction of the harvested 
tissues, a conversion of mRNA into cDNA, and quantified using qRT-PCR.  Fold 
changes between the control and treated group were calculated using the 2
-ΔΔ
 
CT
 method.  
Interleukin-10 was significantly up regulated at the ileocecal junction and ceca on day 
five, the ceca on day 10, 13, and 17, the ileocecal junction on day 17, and significantly 
down regulated in the ceca day 20.  Interleukin-1β was significantly up regulated on day 
5 in the ileocecal junction and ceca, the ceca on days 10 and 13, and significantly down 
regulated in the ileocecal junction on day 20.  No significant changes in gene expression 
were seen in the Meckel‟s diverticulum at any point during the course of the study.  
Extreme outliers were excluded from statistical analysis but are the topic of further 
investigations of the turkey‟s immune response.   
 
Introduction 
Coccidiosis, characterized by diarrhea and enteritis, is a universal problem in the 
poultry industry.  Caused by various species of Eimeria, the disease costs an estimated 
$3 billion worldwide each year (Dalloul and Lillehoj, 2006).  These single-cell protozoa 
are species- specific obligate intracellular parasites.  Seven species of Eimeria are known 
to infect the turkey.  Four of them are considered pathogenic and of economic 
significance, Eimeria meleagrimitis, Eimeria dispersa, Eimeria gallapovonis, and 
Eimeria adenoeides (Saif, 2003; Charlton, 2006).  The industry has heavily relied on the 
use of chemicals since the first sulfur based anti-coccidial chemotherapeutic drug 
appeared in 1939 (Long, 1984) to control the disease.  Species of Eimeria easily develop 
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resistance to chemicals making them less effective for continuing treatment (Li et al., 
2004).  Chapman and Rathinam (2007) determined the majority of field isolate strains of 
Eimeria in turkey facilities are either fully or partially resistant to the commonly used 
ionophore monensin.  
Coccidiosis vaccination appears to be a viable option but side effects have 
limited its acceptance (Danforth, 1998).  There have been several contradictory reports 
regarding bird performance and vaccination.  Vaccinated bird performance is not always 
equivalent to what is typically seen with birds treated with prophylactic medications 
(Danforth, 1998).  Although mortality appears to be the same (Rojs et al., 2007), several 
reports concur that vaccinated birds exhibit a post vaccinal set back in weight gain 
(Chapman, 1996; Danforth, 1998; Williams, 1998).  Studies indicate that vaccinated 
birds exhibit compensatory growth and are comparable in weight to unvaccinated and 
unmediated controls at the time of market (Danforth, 1998; Li et al., 2005).  
Additionally, vaccinated birds tend to have poorer feed conversion when compared to 
medicated birds (Li et al., 2005).  However, production costs of both vaccinated and 
medicated birds appear to be similar (Lee et al., 2009).  
In addition to inconsistent effect on growth rate, consistent uniform vaccination 
is difficult to obtain orally.  Coccivac-T® (Intervet/Schering Plough Animal Health, 
Summit, NJ) coccidiosis vaccine is typically applied at the hatchery via a spray cabinet.  
Poults acquire the vaccine via the ingestion of oocysts while preening each other 
(Coccivac-T® Instructions).  The first dose of the vaccine is critical in acquiring 
protection.  If poults do not receive an initial dose at the time of hatch, it is possible that 
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the exposure in the brooder house will be too high and result in adverse growth effects or 
mortality (Dasgupta and Lee, 2000).  Uniform consumption of vaccine oocysts is critical 
for the uniform development of immunity (Dasgupta and Lee, 2000).  Higher doses of 
oocysts are associated with decreased growth in chickens (Hu et al., 2000), but not 
necessarily with lesion scores (Conway et al. 1999).  Weight gain, feed consumption, 
and feed conversion may be a better way to analyze coccidial control of a product rather 
than traditional intestinal lesion scoring.  Lesion scoring fails to measure oocyst dose 
(Conway et al., 1999).  
 
Avian Immune Response 
 The avian immune response to Eimeria infections appears to be very complex.  
The immune mechanisms involved are dependent upon the area of the gastrointestinal 
tract that is parasitized, the Eimeria species involved in the infection, as well as the 
developmental stage of the parasite (Lillehoj, 1998; Talabia and Mulcahy, 2005).  When 
Eimeria are accompanied with other pathogens, such as Clostridium perfringens, the 
immune mechanisms involved become even more complex (Collier et al., 2008).  
Understanding how the avian immune system responds to enteric pathogens, particularly 
Eimeria, may provide insight and better understanding on how to combat the coccidiosis 
and associated diseases such as necrotic enteritis and gangrenous dermatitis.  Previous 
studies in the chicken indicate the up regulation of IL-1β (Kaiser et al., 2004), IL-2, IL-
5, IL-6, IL- 10, (Yun et al., 2000), and IFN-γ (Lillehoj, 1998) across regions of the 
gastrointestinal tract in response to challenges with Eimeria.  A cDNA microarray of 
 42 
over four-hundred genes in the intestinal intraepithelial lymphocytes during primary and 
secondary Eimeria maxima infections in leghorn chickens revealed significant changes 
in IL-1β, IL-2, IL-6, IL-8, IL-15, and IL-18 (Kim et al., 2008).  
 
Interleukin-10 
Interleukin-10, secreted by activated macrophages and T-regulatory cells, is one 
of the most important immunoregulatory cytokines.  It helps to maintain balance of the 
innate and cell medicated immune responses by inhibiting activated macrophages 
(Abbass et. al, 2007) and consequently inflammation (Kaiser et al., 2004).  During peak 
parasitic infections in chickens, IL-10 expression is elevated.  The increase in IL-10 may 
be an attempt of the parasite to evade macrophage-mediated destruction by suppressing 
the host‟s inflammatory response (Collier et al., 2008).   
 
Interleukin -1β 
Interleukin-1β, a pro-inflammatory cytokine produced by the macrophages, 
endothelial cells, and epithelial cells, mediates the inflammatory response of the host.  
The level of response or inflammation depends on the amount of IL-1β produced.  Small 
quantities result in local inflammation.  Large concentrations of IL-1β enter the blood 
stream, stimulate the synthesis of acute phase plasma proteins as part of the early innate 
immune response, and stimulate the production of IL-6, which promotes the growth of 
B-lymphocytes (Abbass et al., 2007), and increases chemokine and corticosterone 
production (Hilton et al., 2002).  Although IL-1β appears to have a similar function in 
 43 
birds as it does in mammals, the location of genetic loci on the chromosome is not 
similar to the mammalian analogue (Abbass et al., 2007).  Quantitative real time 
polymerase chain reaction (qRT-PCR) analysis has shown an 80-fold increase in IL-1β 
gene expression seven days post challenge with Eimeria tenella in chickens.  Similarly, 
challenges with Eimeria maxima tend to up regulate IL-1β gene expression but to a 
much lesser extent (Kaiser et al., 2004). 
 
Gene Expression 
 Gene expression profiling of immune related components, such as cytokines and 
Toll-like receptors, throughout the course of infections may provide insight to 
controlling particular diseases (Abasht et al., 2008).  The characterization of mucosal 
immune related genes in the chicken is to some extent focused on responses to infections 
with Salmonella, although limited data concerning coccidial infections in the chicken is 
available.  Gene profiling research in the turkey is absent in the peer reviewed literature.  
Gene expression is accurately quantified using qRT-PCR through the extraction of 
mRNA in the biological sample and amplification of targeted genes via sequence 
specific primers and probes (Roth, 2002).  Endogenous genes, such as, such as 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) are used as internal control 
references (Zhou et al., 2010).  Livak and Schmittgen (2001) described the 2
-ΔΔ
 
CT
 
method to calculate and analyze gene expression data acquired using qRT-PCR.   
Based on Toll-like receptor mRNA expression in the duodenum and cecal 
tonsils, native breeds of chickens in India are immunologically more competent and 
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disease resistant compared to the commercial equivalent (Dhinakar Raj et al., 2009).  
The selection of increased performance, such as growth, negatively affects the immune 
response (van Hemert et al., 2006; Dhinakar Raj et al., 2009).  Similarly, comparing 
gene expression in fast and slow growing lines of broilers indicates distinct differences 
in gene expression in the jejunum when challenged with Salmonella (van Hemert et al., 
2006).  The faster growing chicken line responds to the challenge with an increase in 
genes that enhance T cell activation while the slower growing line responds much 
differently and more efficiently with an increase in macrophage activation.  The different 
responses seen between the fast and slow growing broiler lines to the same pathogen 
may potentially explain the variations in susceptibly to Salmonella (van Hemert et al., 
2006) or potentially other pathogens.   
The progression of the coccidiosis and its characteristics between the chicken and 
the turkey are somewhat different therefore, data acquired in the chicken may not be not 
fully applicable to the turkey.  Different species of Eimeria infect the turkey than the 
chicken and the coccidial life cycle is shorter in turkeys.  Non-pathogenic species of 
Eimeria are also found in the turkey‟s gastrointestinal tract making diagnosis more 
complex (Saif, 2003; Charlton, 2006).  Although coccidiosis is very common in the 
turkey industry, the disease often times goes undiagnosed (Saif, 2003).  Lesions tend to 
heal more quickly in the turkey and are may be missed upon necropsy when clinical 
signs are observed (Saif, 2003).  This may be due to the shallow depth of the epithelial 
cells that the coccidia invade.  
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Objectives  
The first objective of this study was to examine the effects variable doses of 
coccidiosis vaccine, 0x, 1/2x, 1x, or 2x manufacturers available dose, on the day of hatch 
had on body weight and vaccine induced intestinal lesions during peak oocyst shedding 
over the course of 20 days.  The second objective of the study was to investigate changes 
in mucosal gene expression in the tissue adjacent to the Meckel‟s diverticulum, ileocecal 
junction, and ceca.  Understanding the turkey‟s response to coccidiosis vaccines may 
disease provide helpful insight to controlling it in the future.  
 
Materials and Methods 
Experimental Design 
Five-hundred newly hatched Hybrid® (Ontario, Canada) turkey hen poults were 
acquired from a recycled Willmar Poultry Company (Willmar, MN) breeder flock 20 
weeks into production.  Poults were serviced according to routine hatchery procedures, 
randomized into four treatment groups, and gavaged with four different doses of 
Coccivac-T® (TCV-4) (Serial Number 94380002) (Intervet/Schering-Plough Animal 
Health, Summit, NJ) coccidiosis vaccine comprised of the equivalent of 0 x, ½ x, 1x, or 
2x the manufactures available dose.  According to the specifications, the vaccine 
consisted of live oocysts of Eimeria adenoeides, Eimeria meleagrimitis, Eimeria 
gallopavonis, and Eimeria dispersa.  Based on hemocytometer counts, the standard 
vaccine dose was 500 oocysts mixed in 0.28 mL solution.  The vaccine was mixed 
according to the manufacturer‟s instructions using distilled water and green dye.  Each 
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bird was gavaged with 0.28 mL of solution.  The first treatment group consisted of a 
twofold vaccine dose.  Vaccine was diluted in distilled water and green dye and 
contained approximately 1,000 oocysts.  The second treatment group received the 
standard vaccine dose of 500 oocysts.  The third group received the equivalent of one-
half of a dose, 250 oocysts.  The fourth group served as a control group and received a 
mixture of distilled water and dye.  Each group was randomized again within itself into 
four replicates of 32 birds per replicate.  Birds within each replicate were color-coded 
with a marker on the top of the head to ensure proper identification when the birds were 
removed from the pens and taken to the diagnostic laboratory for tissue collection.  
All four replicates of each treatment group were placed in individual pens in 
separate identical isolation room.  The pen and room setups were similar to commercial 
operations.  The litter consisted of wood shavings and feed and water was available ad 
libitum. The diet consisted of a (Nutrena Naturewise® Gamebird Starter Crumbs 91183 
NR 0504) (Runnings®, Willmar, MN) non-medicated ration with a minimum of 27% 
crude protein.  Poults were initially placed within cardboard rings in each pen; these 
rings were removed at three days of age.  Based on oocyst shedding patterns seen in a 
previous study, birds were euthanized at 5, 10, 13, 17, and 20 days post vaccination.  On 
the day of the scheduled sacrifice, a fecal sample from each treatment group was taken 
and examined underneath the microscopically to ensure oocyst shedding was indeed 
occurring and the controls remained negative. 
Five birds were randomly selected from each pen, 20 birds per treatment group, 
euthanized on the scheduled sacrifice day via cervical dislocation, and weighed.  
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Sampling locations were selected based on the localization of the species of Eimeria 
(Saif, 2003).   A  2  cm  cross  section  of  the  small  intestine  centered  over  the 
Meckel‟s diverticulum (MD), the ileocecal junction(ICJ) and middle of the ceca (Ce) 
were excised and immediately placed in individual labeled tubes with 35 mL of 10% 
neutral buffered formalin (Fisher Scientific, Fremont, CA) and stored at 4° C.  An 
adjacent approximate 0.4 g section of the intestine was collected, weighed, fecal content 
gently removed, and immediately placed in individual labeled tubes with 0.3 mL of 
RNAlater® (Qiagen®, Valecia, CA).  The samples were stored at 4°C for 24 hours and 
then stored at -80°C. 
Formalin fixed tissues were sent to the Imaging Center at the University of 
Minnesota in St. Paul, MN for histological processing.  After fixation, the tissue was 
dehydrated in varying concentrations of alcohol ranging from 30%-90%.  The intestinal 
segments were cut into three sections and embedded in Paraplast for cross sectioning.  A 
five µm transverse slice was sectioned, placed on a microscope slide, and stained with 
hematoxylin-eosin.  Slides were scanned in using a Logitech® (Fredmont, CA) camera 
modified to fit a Nikon® (Nikon Inc., Melville, NY) stereoscope at a fixed zoom of 
200x.  The Gnu image manipulation program (GIMP) (GNOME Foundation, Groton, 
MA) was used to acquire measurements.  The scaling ratio of 179.33 pixels/mm was 
determined from images of a fixed scale.  Three measurements from the tip of the villus 
extending down to the base of the lamina propria, width of the villus, and muscularis 
mucosae thickness were taken from two animals in each replicate.  Measurement types 
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were selected based on the lesions that the species of Eimeria infecting the turkey 
produce. 
 
Gene Expression Analysis 
RNA was extracted from the intestinal sections from the first two animals in each 
replicate of the control and twofold vaccine dose group using an RNeasy® Plus Mini Kit 
(Qiagen®, Valencia, CA).  The intestinal tissues were removed from the tube containing 
RNAlater® and cut in half.  Half of the tissue was placed in a 2 mL microfuge tube and 
the retention tissue placed back in the tube containing the RNAlater® and stored in a -
20° C freezer.  Total RNA was isolated using an RNeasy® Plus Mini Kit (Qiagen) 
according to the manufacturer‟s instruction and stored at -80°C.  The quantity of RNA in 
each sample was assessed using a NanoDrop® spectrophotometer.  Samples that 
contained less than 100 ng per µl were concentrated using a freeze centrifugal vacuum 
concentrator.  After concentration, if the RNA content in the sample was still less than 
100ng/µl the sample was not used.  One microgram of RNA from each sample was 
converted to cDNA by incubating with one μl of 20X RT Enzyme Mix (High Capacity 
RNA to cDNA Kit, Applied Biosystems, CA) in a final volume of 20 μl on a thermal 
cycler.  The reaction was incubated at 37°C for 60 minutes and stopped by heating at 
95°C for 5 minutes.  The cDNA was then diluted to 200 μl with 0.1X TE buffer and 
stored at -20°C. Amplification was performed on a GeneAmp 7900 Sequence Detection 
System (Applied Biosystems) using 394-well plate.  Each qRT-PCR reaction contained  
μl of diluted cDNA, 1 μl of 20X primers/probe Mix, 10 μl of 2× TaqMan Universal 
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Master Mix (Applied Biosystems), and H2O in a final volume of 20 μl.  The thermal 
profile consisted of an initial hold at 50 °C for 2 min, followed by a single denaturation 
at 95 °C for 10 min, and then 40 cycles of 95 °C for 15 s, 60 °C for 60 s. Duplicate PCR 
reactions were performed for each sample cDNA.  The resulting threshold cycle values 
were normalized to the endogenous GAPDH control gene and were calculated using the 
2
-ΔΔCT
 method (Livak and Schmittgen, 2001).  The ΔCT values between the treated and 
control group were compared and differences in expression of the IL-10 and IL-1β were 
expressed as fold changes.  Primer and probe sequences used in qRT-PCR are presented 
in Table 1. 
 
 Table 1.  Real-time RT-qPCR primer and probes sequences of the targeted genes.  
Gene Forward Primer Reverse Primer TaqMan MGB 
Probe 
Accession 
Number  
GAPDH CTCCTGTGACT
TCAATGGTGA
CA 
CAGGAAACA
AGCTTGACAA
AATGGT  
CCAGCACCCGC
ATCAA-FAM  
GQ184819.1 
IL-10 TTTGGCTGCCA
GTCAGTGT 
GCTGGTGCTG
GTCTTCATG  
AAGCGCAGCAT
CTCT-FAM 
AM493432.1 
IL-1β AAGGGCTACA
AGCTCTACAT
GTC 
CGTCGGCTTC
CTCCAGTT   
CCGAGCCCACG
CTGC-FAM 
DQ393271.1 
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Statistical Analysis  
Statistical analysis of the body weight and the histological measurements were 
done using a one-way ANOVA and a Duncan‟s Multiple Range Test using SPSS® 
Graduate Pack 16.0 for Windows (SPSS® Inc, Somers, NY).  Probability (p)-values 
<0.05 were considered significant.  Fold and gene expression changes were analyzed 
with a Student‟s T-test using SPSS® of the ΔCT in the treated and control groups.   
Results and Discussion 
The day following vaccination, considerable amounts of green droppings were 
present in the litter of all groups most likely due to the dye used with the vaccine.  
Clinical symptoms such as blood in the droppings, ruffled feathers, lethargic birds and 
huddling appeared in the vaccinated appeared at various times throughout the course of 
the study.  Inflammation and intestinal wall thickening was noted in all vaccinated 
groups starting on day five.  Distended ceca, cecal cores, fibrino-necrotic tissue and 
mucosal damage in the ceca were present in all vaccinated groups day 13 (Figs. 6, 7, 8, 
and 9).   
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Fig. 6. Ceca distended, filled with fibrino-necrotic material. 
 
 
Fig. 7. Cecal cores visible through the intestinal wall. 
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Fig. 8. Cecal cores - fibrino-necrotic material present in the lumen. 
 
 
Fig. 9. Fibrino-necrotic material in the lumen and mucosal damage in the form of focal 
ulcerations and hemorrhaging. 
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Histological examination of the ceca, at an independent laboratory (Dr. Daniel 
Shaw, University of Missouri), revealed the intestinal lumen to be filled with fibrino-
necrotic material with numerous oocysts (Fig. 10) in addition to the epithelial cells 
containing coccidia at numerous stages of development (Fig. 11 and 12).  Cellular 
infiltration of the lamina propria musosae with heterophils and macrophages and 
substantial villus atrophy was also observed (Fig. 13).  An intact villus from the control 
group is shown in Fig. 14.  
 
 
 
Figure 10.  Lumen of the ceca filled with fibrino-necrotic material and coccidia.  
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Figure 11.  Epithelial cells in the ceca contain coccidia at numerous stages of 
development.   
 
 
Figure 12.  Coccidia at numerous stages of development.  (Higher magnification) 
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Figure 13.  Atrophy of the villus. 
 
 
Figure 14.  Control villus. 
 
Body weights taken at the time of sacrifice  revealed a significant difference 
between the treated and control groups starting at day five.  (Fig.6)  Oocyst dose and 
body weight were inversely related through day 17.  These findings are consistent with 
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previous research in the chicken (Hu et al., 2000).  Infection with a single oocyst can 
result in the production of up to one million oocysts (Conway et al., 1991).  Very small 
differences in the challenge dose may produce major effects on the poult.  Thus, lesions 
are difficult to control because of uneven oocyst consumption.  The second and third 
cycles of the Eimeria life cycle are dependent upon the coprophagic nature of the 
individual and oocyst shedding of the flock.  A longer grow out period is needed to 
determine if poults will exhibit compensatory growth, if the amount of growth is 
consistent among treated groups, and if gain is sufficient to be comparable in 
bodyweight to the controls.   
 
 
Figure 15.  Body weight at the time of tissue collection.  P-values <0.05 were considered 
significant.  
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Intestinal Measurements 
The marked inflammation noted upon necropsy in the vaccinated groups can be 
clearly observed in the intestinal histopathology  Significant differences in the 
measurement taken from the tip of the villus to the base of the lamina propria mucosae 
were seen adjacent to the Meckel‟s diverticulum on day five and day 20 post vaccination 
(Fig. 7).  The measurement was significantly larger in all vaccinated groups when 
compared to the controls on day five, most likely due to inflammation.  On the contrary, 
measurements obtained from day 20 indicated the control group to have significantly 
longer villus than the 1/2x and 2x dose group.  Few differences in villus width were 
seen, although there was a large decrease in width across all groups on day 17. 
Muscularis mucosae thickness was significantly thicker in the control group on day 20.  
 
 
Figure 16.  Intestinal measurements taken from the Meckel‟s diverticulum. P-values 
<0.05 were considered significant. 
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Figure 16 continued.  
 
 
Height and width measurements taken at the illeocecal junction were more 
variable and not necessarily correlated with vaccine dose (Fig. 17).  Height 
measurements appear to converge on day 13.  Significant differences in the illeocecal 
muscularis mucosae were seen between the control and 2x group on day17.  Similar 
variability was seen in measurements taken in the ceca (Fig. 18).  The control group had 
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the smallest villus width on day five and the largest on day 20.  No significant 
differences were seen on day 20 regarding height and muscularis mucosae thickness 
between the groups.   
 
 
 
 
Figure 17.  Intestinal measurements taken from the illeocecal junction.  P-values <0.05 
were considered significant. 
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Figure 17 continued.  
 
 
 
Figure 18. Intestinal measurements taken from the ceca.  P-values <0.05 were considered 
significant. 
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Figure 18. Continued. 
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consumption.  This may be due do the coprophagic nature if the individual and variable 
consumption of oocyst.  Alternative approaches to the traditional lesion scoring such as 
weight gain, feed consumption, and feed conversion may be a better way to analyze the 
effect of coccidiosis in turkeys (Conway et al., 1999).   
There were no significant changes in the mucosal gene expression of IL-10 and 
IL-1β in the intestinal tissue adjacent to the Meckel‟s diverticulum throughout the course 
of the study (Fig. 19).  The lack of significant immunological activity in this area may 
indicate the lack of immunological response. 
 
 
Figure 19.  Fold change in mRNA gene expression in the Meckel‟s diverticulum. An „*‟ 
denotes a significant differnce. P-value was <0.05. 
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Figure 20. Fold change in mRNA expression in the ileocecal junction. An „*‟ denotes a 
significant differnce. P-value was <0.05.  
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Figure 21. Fold change in mRNA expression in the ceca. An „*‟ denotes a significant 
differnce. P-value was <0.05.  
 
The amount of immunological activity occuring in the ceca indicates that the 
species within the vaccine highly paracitize this region of the gastrointestinal tract.  
Interluekin-10 was much more active than IL-1β that through day 17, IL-10 was trying 
to control the immune response in the ceca.   
 On average, there was one obvious outlier per collection day in the treated group.  
The massive outliers, excluded from the statistical results, are of particular interest for 
further investigations.  Outliers were animal specific and across all tissue types.  For 
example, on day 5 an individual animal was an outlier in IL-1β in all three tissues types 
that were collected.  The animal had a 26-fold increase near the Meckel‟s diverticulum 
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and a 111 fold increase across both the ileocecal junction and ceca in the mucosal gene 
expression of IL-1β.  The normal group saw a 1.5 fold increase at the Meckel‟s 
diverticulum, a seven fold increase at the ileocecal junction and a five fold increase in 
IL-1β in the ceca.  Similalry, a measureable amount of GAPDH was recovered from an 
individual on day 20 but measurable amounts of IL-10 or IL-1β were not, possibly 
indicating a lack of immune response. A massive ouliter on day five post vaccination is 
of particular interest because the individual was gavaged the same dose as other 
individuals that did not respond in the same mannar. For an unknown reason the outlier 
had what appears to be an uncontrolled or excessive immune response.  Powell et al. 
(2009) reported an uncontrolled immune response in the turkey following challenges 
with another enteric pathogen, Histomonas meleagridis.  It would be of interest to 
investigate why the individual outliers were seen.   
Additional research regarding the turkey‟s immune response to pathogens, 
particularly coccidiosis, is needed to understand the vaccine and bird interaction.  
Coccivac-T® contains the original strains of Eimeria when it was first formulated in 
1989 (Williams, 2002).  The vaccine has not changed but the immune function of the 
turkey has.  Several researchers indicate that through the selection of a more growth 
efficient bird, both the chicken and turkey industry has inadvertently selected for birds 
with a weaker immune system (Genovese et al., 2006; van Hemert et al., 2006; 
Genovese et al. 2007, Dhinakar Raj et al., 2009).  Particular attention must be given to 
the turkey‟s immune response and the factors that contribute to the individual massive 
variation when gavaged with similar amounts of oocysts.  Full grow out trials are needed 
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to examine the long term side effects of coccidiosis vaccination on weight gain, feed 
consumption, and feed conversion.  
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CHAPTER VI 
CONCLUSIONS 
 
Coccidiosis vaccine induced oocyst shedding, intestinal lesions, and mucosal 
gene expression in Hybrid® turkey hens vaccinated on the day of hatch were 
investigated.  The first study examined the vaccine induced oocyst shedding patterns 
under experimental conditions through daily fecal sampling and gross observations.  
Peak shedding occurred at 5-6, 13- 17 and 19- 20 days post vaccination.  All four 
replicates had similar shedding patterns.  Oocyst shedding ceased at approximately 20 
days.  Management practices appeared to affect oocyst shedding patterns and may affect 
vaccine efficacy.  Clinical signs such as lethargic birds and bloody droppings coincided 
with peaks in oocyst shedding but may be attributed to the vaccine dosage level from 
gavaging.  Weekly body weights and rate of gain correlated with vaccine cycling.  The 
possibility of compensatory growth requires further investigation.     
The second study examined vaccine induced lesions at various dosage levels and 
mucosal gene expression in birds vaccinated with 0x, 1x, 1/2x, and 2x the manufactures 
available dose Coccivac-T®.  Poults were sacrificed at 5, 10, 13, 17, and 20 days post 
vaccination based on oocyst shedding patterns seen in the previous study.  Body weight 
and intestinal sections over the Meckel‟s diverticulum, ileocecal junction, and middle of 
the ceca were collected for histological examination and gene expression.  Body weight 
was inversely related to vaccine dose.  Measurements from the tip of the villus to the 
base of the lamina propria mucosae, villus width, and muscularis mucosae thickness 
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were taken from the histological sections.  Intestinal measurements did not necessarily 
correlate with the vaccine dose, although there appeared to be some correlation on day 
five.  IL-10, IL-1β, and GAPDH gene expression was measured using RT-qPCR.  There 
were no significant changes in the mucosal gene expression of IL-10 and IL-1β in the 
intestinal tissue adjacent to the Meckel‟s diverticulum throughout the course of the 
study.  On day five post vaccination IL-10 and IL-1β were significantly upregulated in 
the ileocecal junction.  Interleukin-10 was significantly upregulated on day 17 and IL-1β 
was significanlty down regulated on day 20 in the ileocecal junction.  Both IL-10 and 
IL-1β were significanlty upregulated in th ceca day 5, 10, and 13 post vaccination.  
Interleukin-10 was significnalty upregulated in the ceca on day 17 and significantly 
down regulated on day 20.  It appears that IL-10 and IL-1β can be used to study 
coccidiosis in the turkey.  Based on gross pathology, histology, and gene expression, 
coccidiosis was most severe in the ceca.  
There was a large individual variation in gene expression and vaccine induced 
intestinal lesions.  Levels of variability were high among the vaccinated groups, 
therefore retained tissue and slides from other animals in the same group need to be 
examined in order to increase sample sizes and reveal significant differences.  Uniform 
application of the vaccine does not appear to result in consistent lesion development and 
immune response.  Unpredictable immune responses have been previously described in 
the turkey following infections with the enteric pathogen, Histomonas meleagridis 
(Powell et al., 2009).  A similar immune response may occur with coccidiosis.  As 
turkeys are bred for higher body weight and rate of gain increases, inadvertently there is 
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a negative impact on immune function (van Hemert et al., 2006, Dhinakar Raj et al., 
2009).  With the decreased immune function, live vaccines, such as Coccivac-T®, may 
need continual modifications such as attenuation to the formulation to reduce adverse 
side effects yet remain effective in the control of the disease.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 70 
REFERENCES 
 
 
 
Abasht, B., Kaiser, M.G., and Lamont, S.J. 2008. Toll-like receptor gene expression in 
the cecum and spleen of advanced intercross line chicks infected with Salmonella 
enterica serovar enteritidis. Veterinary Immunology and Immunopathology 123: 
314-323.  
 
Abbas, A. K., Lichtman, A.H., and Pillai, S. 2007. Cellular and Molecular Immunology. 
6 ed. Saunders Philadelphia. 
 
Alfaro, D. M., Silva, A.V.F., Borges, S.A., Maiorka, F.A., Vargas, S., and Santin, E. 
2007. Use of Yucca schidigera extract in broiler diets and its effects on 
performance results obtained with different coccidiosis control methods. Journal 
of Applied Poultry Research 16: 248-254.  
 
Allen, P. C., Danforth, H., and Levander, O.A. 1997. Interaction of dietary flaxseed with 
coccidia infections in chickens. Poultry Science 76: 822-827. 
 
Andrews, J. 1933. The control of poultry coccidiosis by the chemical treatment of litter. 
American Journal of Hygiene 17: 466-490.  
 
Bar -Shira, E., Sklan, D., and Friedman, A. 2003. Establishment of immune competence 
in the avian GALT during the immediate post-hatch period. Development and 
Comparative Immunology 27: 147-157.  
 
Batungbacal, M. R., Hilomen, G.V., Luis, E.S., Centeno, J.R., and Carandang, N.F. 
2007. Comparative efficacy of oregano extract and amprolium in the control of 
coccidiosis and their effects on broiler performance. Philippine Journal of 
Veterinary Medicine 44: 91-99. 
 
Brenes, A., and Roura, E. 2010. Essential oils in poultry nutrition: Main effects and 
modes of action. Animal Feed Science and Technology 158: 1-14.  
 
Ceruti, R., Ferrazzi, V., Gavazzi, L., Gallazzi, D., and Grill, G. 2005. Efficacy in the 
field of two anticoccidial vaccines for broilers. Italian Journal of Animal 
Sciences 4: 259-262.  
 
Chapman, H. D. 1992. Immunity to Eimeria in broilers reared on nicarbazin and 
salinomycin. Poultry Science 71: 577-580. 
 
 71 
Chapman, H. D. 1996. Administration of a coccidiosis vaccine to day-old turkeys via the 
eye and development of immunity to Eimeria species. Poultry Science 75: 1496-
1497. 
 
Chapman, H. D. 1999. The development of immunity to Eimeria species in broilers 
given anticoccidial drugs. Avian Pathology 28: 155-162.  
 
Chapman, H. D. and Rathinam, T. 2007. Sensitivity of field isolates of Eimeria to 
monensin in the turkey. Avian Diseases 51: 954-957.  
 
Charlton, B. R. (Editor), 2006. Avian Disease Manual. American Association of Avian 
Pathologists, Jacksonville, FL. 
 
Christaki, E., Florou-Paneri
, 
P., Giannenas
 
, I., Papazahariadou, M., Botsoglou, N.A. and 
Spais, A.B. 2004. Effect of a mixture of herbal extracts on broiler chickens 
infected with Eimeria tenella. Animal Research 53: 137-144.  
 
Collier, C. T., Hofacre, C.L., Payne, A.M., Anderson, D.B., Kaiser, P., Mackie, R.I., and 
Gaskins, H.R. 2008. Coccidia-induced mucogenesis promotes the onset of 
necrotic enteritis by supporting Clostridium perfringens growth. Veterinary 
Immunology and Immunopathology 122: 104-115.  
 
Conway, D. P., Dayton, A.D., and McKenzie, M.E. 1999. Comparative testing of 
anticoccidials in broiler chickens: The role of coccidial lesion scores. Poultry 
Science 78: 529-535.  
 
Conway, D. P. and McKenzie, M.E. 1991. Poultry Coccidiosis- Diagnostic and Testing 
Procedures. 2 ed. Pfizer, New York. 
 
Dalloul, R. A., and Lillehoj, H.S. 2005. Recent advances in immunomodulation and 
vaccination strategies against coccidiosis. Avian Diseases 49: 1-8.  
 
Dalloul, R. A., Lillehoj, H.S., Klinman, D.M., Ding, X., Min, W., Heckert, R.A., and 
Lillehoj, E.P. 2005. In ovo administration of CpG oligodeoxynuclelotides and the 
recombinant microneme protein MIC2 protects against Eimeria infections. 
Vaccine 23: 3108-3113.  
 
Dalloul, R.A. and Lillehoj, H.S. 2006. Poultry coccidiosis: recent advancements in 
control measures and vaccine development. Expert Reviews of Vaccines 5: 143-
163 
 
Danforth, H. D. 1998. Use of live vaccines in the control of avian coccidiosis: 
Experimental studies and field trials. International Journal for Parasitology 28: 
1099-1109. 
 72 
 
Dasgupta, T., and Lee, E.H. 2000. A gel delivery system for coccidiosis vaccine: 
Uniformity of distribution of oocysts. Canadian Veterinary Journal 41: 613-616. 
 
Dhinakar Raj, G., Chazhavel Rajanathan, T.M., Kumanan, K., and Elankumaran, S. 
2009. Expression profile of toll-like receptor mRNA in an indigenous Aseel 
breed of chicken in India. International Journal of Poultry Science 8: 651-655.   
 
Fitz-Coy, S. January 2010. Personal communication. Intervet Schering-Plough Animal 
Health. Willmar, MN. 
 
Garcia, J. L., Guimarães Jr. J., Headley, S.A., Bogado, A.L., Bungi, F.M., Ramalho, 
D.C., Montemor de Souza, L. 2008. Eimeria tenella: Utilization of a nasal 
vaccine with sporozoite antigens incorporated into Iscom as protection for broiler 
breeders against a homologous challenge. Experimental Parasitology 120: 185-
190. 
 
Genovese, K.J., He, H., Lowry, V.K. Swaggerty, C.L., and Kogut, M.H. 2006. 
Comparison of heterophil functions of modern commercial and wild-type Rio 
Grande turkeys. Avian Pathology. 34: 217-223.  
 
Genovese, K.J., He, H., Lowry, and Kogut, M.H. 2007. Comparison of MAP and 
tyrosine kinase signaling in heterophils from commercial and wild-type turkeys. 
Developmental and Comparative Immunology. 31: 927-933. 
 
Giannenas, I., Florou-Paneri, P., Papazahariadou, M., Botsoglou, N.A., and Spais, A.B. 
2003. Effect of dietary supplement with oregano essential oil on performance of 
broilers after experimental infection with Eimeria tenella. Archives of Animal 
Nutrition 57: 99-106. 
 
Haghighi, H.R., Abdul-Careem, M.F., Dara, R.A., Chambers, J.R., and Sharif, S. 2008. 
Cytokine gene expression in the chicken cecal tonsils following treatment with 
probiotics and Salmonella infection. Veterinary Microbiology 126: 225-233. 
 
Hilton, L. S., Bean, A.G.D., and Lowenthal, J.W. 2002. The emerging role of avian 
cytokines as immunotherapeutics and vaccine adjuvants. Veterinary Immunology 
and Immunopathology 85: 119-128. 
 
Hume, M. E., Clemente-Hernandez, S., and Oviedo-Rondont, E.O. 2006. Effects of feed 
additives and mixed Eimeria species infection on intestinal microbial ecology of 
broilers. Poultry Science 85: 2106-2111. 
 
 73 
Johansen, C. H., Bjerrum, L., and Pederson, K. 2007. Impact of salinomycin on the 
intestinal microflora of broiler chickens. Acta Veterinaria Scandinavica 49: 30-
37. 
 
Kaiser, P., Rothwell, L., Avery, S., and Balu, S. 2004. Evolution of interleukins. 
Development and Comparative Immunology 28: 375-394.  
 
Karlson, T. and Reid, W.M. 1978. Development of immunity to coccidiosis in chickens 
administered anticoccidials in feed. Avian Diseases 22: 487-495. 
 
Kim, C.H., Lillehoj, H.S., Bliss, T.W., Keeler Jr., C.L., Hong, Y.H., Park, D.W., 
Yamage, M., Min, W., and Lillehoj, E.P. 2008. Construction and application of 
an avian intestinal intraepithelial lymphocyte cDNA microarray (AVIELA) for 
gene expression profiling during Eimeria maxima infection. Veterinary 
Immunology and Immunopathology 124: 341-354. 
 
Lee, J. T., Broussard, C., Fitz-Coy, S., Burke, P., Eckert. N.H., Stevens, S.M., Anderson, 
P.N., Anderson, S.M., and Caldwell, D.J. 2009. Evaluation of live oocyst 
vaccination or salinomycin for control of field-strain Eimeria challenge in 
broilers on two different feeding programs. Journal of Applied Poultry Research 
18: 458-464. 
 
Li, G. Q., Kanu, S., Xiao, S.M., and Xiang, F.Y. 2005. Responses of chickens vaccinated 
with a live attenuated multi-valent ionophore-tolerant vaccine. Veterinary 
Parasitology 129: 179-186. 
 
Li, G. Q., Kanu, S., Xiang, F.Y., Xiao, S.M., Zhang, L., Chen, H.W. and Ye, H.J,. 2004. 
Isolation and selection of ionophore-tolerant Eimeria precocious lines: E. tenella, 
E. maxima, and E.acervulina. Veterinary Parasitology 119: 261-276. 
 
Lillehoj, H. S. 1998. Role of T lymphocytes and cytokines in coccidiosis. International 
Journal for Parasitology 28: 1071-1081.  
 
Livak, K.J., and Schmittgen, T.D. 2001. Analysis of relative gene expression data using 
real-time quantitative PCR and the 2
-ΔΔCT
 method. Methods 25: 402-408. 
 
Long, P.L. 1984. Coccidiosis control: Past, present, and future. British Poultry Science 
25: 3-18. 
 
MacKinnon, K.M., He, H., Nerren, J.R., Swaggerty, C.L., Genovese, K.J., and Kogut, 
M.H. 2009. Expression profile of toll-like receptors within the gastrointestinal 
tract of 2-day-old Salmonella enteriditis infected broiler chickens. Veterinary 
Microbiology 137: 313-319. 
 
 74 
Mathis, G. F. 1993. Toxicity and acquisition of immunity to coccidia in turkeys 
medicated with anticoccidials. Journal of Applied Poultry Research 2: 239-244.  
 
McDonald, V. and Shirley, M.W. 2009. Past and future: Vaccination against Eimeria. 
Parasitology 136: 1477-1489.  
 
Muir, W. I., Bryden, W.L., and Husband, A.J. 2000. Immunity, vaccination and the 
avian intestinal tract. Development and Comparative Immunology 24: 325-342.  
 
Oviedo-Rondon, E. O., Hume, M.E., Hernandez, C., and Clemente-Hernandez, S. 2006. 
Intestinal microbial ecology of broilers vaccinated and challenged with mixed 
Eimeria species, and supplemented with essential oil blends. Poultry Science 85: 
854-860.  
 
Powell, F. L., Rothwell, L., Clarkson, M.J., and Kaiser, P. 2009. The turkey, compared 
to the chicken, fails to mount an effective early immune response to Histomonas 
meleagridis in the gut. Parasite Immunology 31: 312-327.  
 
Roth, C.M. 2002. Quantifying gene expression. Current Issues in Molecular Biology 4: 
93-100.  
 
Rattanaphol, M. and Rattanphol, N. 2002. Efficacy of crude extract from the guava leaf 
Psidium quajava for the prevention of coccidiosis in broilers inoculated with 
Eimeria tenella. Thai Journal of Phytopharmacy 9: 15-23. 
 
Rebel, J., Van Hemert, S., Hoekman, A., Balk, F., Stockhofe-Zurwieden, N., Bakker, D., 
and Smits, M.A. 2006. Maternal diet influences gene expression in the intestine 
of offspring in chicken (Gallus gallus). 2006. Comparative Biochemistry and 
Physiology, Part A 145: 502-508. 
 
Rojs, O. Z., Rataj, A.V., Volk, M., Racnik, J., Dovc, A., Krapez, U., and Cajavec, S. 
2007. Efficacy and benefits of prevention of coccidiosis in broilers by 
vaccination in comparison to anticoccidial drug program. International Journal of 
Environment and Pollution 31: 85-97. 
 
Rose, M. E. 1982. The Biology of Coccidia. Edward Arnold Publishers, London. 
 
Saif, Y. M. (Editor), 2003. Diseases of poultry. Blackwell Publishing, Ames, IA. 
 
Sharman, P. A., Smith, N.C., Wallach, M.G., and Katrib, M. 2010. Chasing the golden 
egg: Vaccination against poultry coccidiosis. Parasite Immunology 32: 590-598.  
 
 75 
Soares, R., Cosstick, T., and Lee, E.H. 2004. Control of coccidiosis in cages egg layers: 
A paper plate vaccination method. Journal of Applied Poultry Research 13: 360-
363.  
 
Stevens, D. A. 1998. Encyclopedia of Immunology. 2 ed. Academic Press Ltd., London. 
 
Talebi, A., and Mulcahy, G. 2005. Partial protection against Eimeria acervulina and 
Eimeria tenella induced by synthetic peptide vaccine. Experimental Parasitology 
110: 342-348. 
 
van Hemert, S., Hoekman, A.J.W., Smits, M.A., and Rebel, J.M.J. . 2006. Gene 
expression responses to a Salmonella infection in the chicken intestine differ 
between lines. Veterinary Immunology and Immunopathology 114: 247-258.  
 
Vermeulen, A. N. 1998. Progress in recombinant vaccine development against 
coccidiosis: A review and prospects into the next millennium. International 
Journal for Parasitology 28: 1121-1130.  
 
Vermeulen, A. N., Schaap, D.C., and Schetters,P.M. 2001. Control of coccidiosis in 
chickens by vaccination. Veterinary Parasitology 100: 13-20.  
 
Waldenstedt, L. 2003. Effect of vaccination against coccidiosis in combination with an 
antibacterial oregano compound in organic broiler production. Aceta Agricultuae 
Scandinavica: Section A, Animal Science 52: 101-109. 
 
Weber, F. H. and Evans, N.A. 2003. Immunization of broiler chicks by in ovo injection 
of Eimeria tenella sporozoites, sporocysts, or oocysts. Poultry Science 82: 1701-
1707. 
 
Williams, R. B. 1998. Epidemiological aspects of the use of live anticoccidial vaccines 
for chickens. International Journal for Parasitology 28: 1089-1098. 
 
Williams, R. B. 2002. Fifty years of anticoccidial vaccines for poultry (1952-2002). 
Avian Diseases 46: 775-802. 
 
Yadav, A., Gupta, S.K. 2007. Effect of ionophores on immunity to Eimeria tenella field 
isolates. Indian Journal of Animal Research 41: 43-47.  
 
Yin, Y., Lei, F., Zhu, L., Li, S., Wu, Z., Zhang, R., Gao, G.F., Zhu, B., and Wang, X. 
2010. Exposure of different bacterial inocula to newborn chicken affects gut 
microbiota development and ileum gene expression. The International Society 
for Microbial Ecology Journal 4: 367-376. 
 
 76 
Yun, C. H., Lillehoj, H.S., and Lillehoj, E.P. 2000. Intestinal immune response to 
coccidiosis. Developmental and Comparative Immunology 24: 303-324. 
 
Zhou, Y.H., Raj, V.R., Siegel, E., and Yu, L. 2010. Standardization of gene expression 
quantification by absolute real-time qRT-PCR system using a single standard for 
marker and reference genes. Biomarker Insights 5: 79-85 
 77 
VITA 
 
Name: Michelle A. Behl 
Address: Department of Poultry Science - Texas A&M University  
 101 Kleberg Bldg. College Station, TX 77843-2472 
 
Email Address: Michelle.Behl@willmarpoultry.com  
 jmabehl@gmail.com 
 
Education:             B.S. Natural Sciences, Poultry Sciences, University of 
Wisconsin- Madison, 2005  
 
